Hemant Phatak
About Hemant Phatak
Hemant Phatak serves as the Head of Global Health Economics and Outcomes Research at Amylyx Pharmaceuticals, where he has worked since 2023. With over 15 years of experience in the field, he has held various leadership roles across multiple organizations, focusing on reimbursement strategy and health economics.
Work at Amylyx Pharmaceuticals
Hemant Phatak serves as the Head of Global Health Economics and Outcomes Research at Amylyx Pharmaceuticals. He has held this position since 2023, working in a hybrid capacity from Cambridge, Massachusetts. In this role, he focuses on health economics and outcomes research to support the company's product development and market access strategies.
Education and Expertise
Hemant Phatak completed his Ph.D. in Health Economics and Outcomes Research at Purdue University from 2002 to 2005. He also holds a Master of Science in Pharmacy Administration from Idaho State University, obtained between 1998 and 2001, and a Bachelor of Pharmacy from the University of Mumbai, earned from 1993 to 1997. He further enhanced his expertise through a Post Doctoral Fellowship at Rutgers University - Newark from 2005 to 2006.
Background
Phatak has over 15 years of experience in health economics, outcomes research, and reimbursement strategy. His career includes significant roles at various pharmaceutical companies, where he has developed expertise across all phases of the product lifecycle, from early development to launch and lifecycle management. His previous positions include leadership roles at Merck, EMD Serono, Acceleron Pharma, and Bristol-Myers Squibb.
Professional Experience
Prior to joining Amylyx Pharmaceuticals, Hemant Phatak held several key positions in the pharmaceutical industry. He was the Executive Director of Evidence Strategy at Genesis Research for six months in 2022 and served as the Head of US Health Economics and Outcomes Research at EMD Serono, Inc. from 2018 to 2020. His experience also includes roles at Acceleron Pharma as VP of Global Market Access and at Bristol-Myers Squibb as Group Director of Global Health Economics and Outcomes Research.
Achievements
Throughout his career, Hemant Phatak has demonstrated extensive experience in supporting products in various therapeutic areas, including specialty and primary care, targeted therapies, immuno-oncology, and rare diseases. His work has contributed to advancing health economics and outcomes research within the pharmaceutical industry, particularly in supporting market access and reimbursement strategies.